The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study

PLoS One. 2012;7(10):e46988. doi: 10.1371/journal.pone.0046988. Epub 2012 Oct 5.

Abstract

Background: Studies have shown that early ART initiation in TB/HIV co-infected patients lowers mortality. One way to implement earlier ART commencement could be through integration of TB and HIV services, a more efficient model of care than separate, vertical programs. We present a model of full TB/HIV integration and estimate its effect on time to initiation of ART.

Methodology/principal findings: We retrospectively reviewed TB registers and clinical notes of 209 TB/HIV co-infected adults with a CD4 count <250 cells/µl and registered for TB treatment at one primary care clinic in a South African township between June 2008 and May 2009. Using Kaplan-Meier and Cox proportional hazard analysis, we compared time between initiation of TB treatment and ART for the periods before and after full, "one-stop shop" integration of TB and HIV services (in December 2009). Potential confounders were determined a priori through directed acyclic graphs. Robustness of assumptions was investigated by sensitivity analyses. The analysis included 188 patients (100 pre- and 88 post-integration), yielding 56 person-years of observation. Baseline characteristics of the two groups were similar. Median time to ART initiation decreased from 147 days (95% confidence interval [CI] 85-188) before integration of services to 75 days (95% CI 52-119) post-integration. In adjusted analyses, patients attending the clinic post-integration were 1.60 times (95% CI 1.11-2.29) more likely to have started ART relative to the pre-integration period. Sensitivity analyses supported these findings.

Conclusions/significance: Full TB/HIV care integration is feasible and led to a 60% increased chance of co-infected patients starting ART, while reducing time to ART initiation by an average of 72 days. Although these estimates should be confirmed through larger studies, they suggest that scale-up of full TB/HIV service integration in high TB/HIV prevalence settings may shorten time to ART initiation, which might reduce excess mortality and morbidity.

MeSH terms

  • Adult
  • Ambulatory Care Facilities
  • Anti-HIV Agents / therapeutic use*
  • Antitubercular Agents / therapeutic use
  • CD4 Lymphocyte Count
  • Coinfection
  • Delivery of Health Care / methods
  • Delivery of Health Care / organization & administration*
  • Female
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy*
  • HIV Infections / mortality
  • Humans
  • Male
  • Proportional Hazards Models
  • Registries
  • Retrospective Studies
  • South Africa
  • Time Factors
  • Treatment Outcome
  • Tuberculosis / drug therapy*

Substances

  • Anti-HIV Agents
  • Antitubercular Agents

Grants and funding

The authors are employed by their respective institutions and are responsible for study design, data collection and analysis, decision to publish, and preparation of the manuscript. There was no additional funding for this study.